Strong Smoke-Free Product Growth
Philip Morris reported $4 billion in net revenues from their smoke-free portfolio, with double-digit adjusted diluted EPS growth in both constant currency and dollar terms. IQOS, ZYN, and VEEV showed strong performance, with IQOS in-market sales growth accelerating to 11.4% in Q2 and 26% US consumer offtake growth in Q2.
Increased Revenue and Earnings
The company achieved over $10 billion in quarterly net revenues for the first time, with organic net revenues growing by more than 8% excluding the Indonesia impact. Adjusted operating income grew by 14.9% organically, with a 20% increase in adjusted diluted EPS.
ZYN's Strong Performance in the US
ZYN's US offtake growth reaccelerated to 36% in June after resolving supply constraints, marking a return to its category-driving position. The company plans to continue its growth trajectory with increased production capacity.
Margin Expansion
There was a 300 basis points organic gross margin expansion in H1, driven by smoke-free growth contributing 190 basis points. This reflects significant profitability increases in smoke-free categories.
Positive Outlook and Updated Guidance
Philip Morris raised their adjusted diluted EPS forecast for the full year to 13% to 15% growth in dollar terms, reflecting strong smoke-free product momentum and improved tax rates.